Edition:
United States

Neurocrine Biosciences Inc (NBIX.OQ)

NBIX.OQ on NASDAQ Stock Exchange Global Select Market

49.51USD
22 Jul 2016
Change (% chg)

$0.43 (+0.88%)
Prev Close
$49.08
Open
$49.13
Day's High
$49.76
Day's Low
$48.91
Volume
202,837
Avg. Vol
453,407
52-wk High
$58.41
52-wk Low
$31.25

NBIX.OQ

Chart for NBIX.OQ

About

Neurocrine Biosciences, Inc. is engaged in the development of pharmaceutical products focused on neurological and endocrine-based diseases and disorders. The Company's two lead late-stage clinical programs are Elagolix, a gonadotropin-releasing hormone (GnRH) antagonist for women's health that is partnered with AbbVie Inc.... (more)

Overall

Beta: 0.66
Market Cap(Mil.): $4,290.34
Shares Outstanding(Mil.): 86.66
Dividend: --
Yield (%): --

Financials

  NBIX.OQ Industry Sector
P/E (TTM): -- 39.80 37.05
EPS (TTM): -1.24 -- --
ROI: -22.56 -5.86 14.35
ROE: -23.84 -4.70 15.56

BRIEF-Neurocrine Biosciences reports Q1 loss per share $0.22

* Q1 earnings per share view $-0.29 -- Thomson Reuters I/B/E/S

May 05 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.